Feed Top Reports Pricing

⌘K

08:00:00·60d

PRReleasevia Quantisnow

Sylvamo Announces Dividend

ByQuantisnow·Wall Street's wire, on your screen.

SLVM· Sylvamo Corporation

Basic Materials

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLVM (Sylvamo Corporation) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

SLVM
Sylvamo Corporation
Basic Materials

Recent analyst ratings

Mar 30UpdateTruist$54.00
Nov 17UpdateBofA Securities-
Dec 11UpdateBofA Securities$96.00
Oct 15UpdateSidoti$100.00
Aug 12UpdateBofA Securities$82.00
Aug 10UpdateRBC Capital Mkts$44.00

Related

PR16d
Sylvamo to Release First Quarter Earnings May 8
SEC22d
SEC Form DEFA14A filed by Sylvamo Corporation
SEC22d
SEC Form DEF 14A filed by Sylvamo Corporation
ANALYST25d
Truist initiated coverage on Sylvamo with a new price target
SEC28d
Amendment: SEC Form SCHEDULE 13G/A filed by Sylvamo Corporation
INSIDER38d
SVP, Operational Excellence Wilczynski Patrick sold $253,680 worth of shares (6,000 units at $42.28), decreasing direct ownership by 14% to 38,313 units (SEC Form 4)
INSIDER45d
VP, Controller,Chief Acct.Off. Ferguson Kevin W sold $105,150 worth of shares (2,500 units at $42.06), decreasing direct ownership by 29% to 6,257 units (SEC Form 4)
SEC48d
SEC Form S-3ASR filed by Sylvamo Corporation

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022